Dongzong Cardiovascular Bio-imaging Registry Study

Launched by JINLING HOSPITAL, CHINA · Mar 19, 2025

Keywords

ClinConnect Summary

The Dongzong Cardiovascular Bio-imaging Registry Study is a large research project aimed at understanding how both our genes and our living environments affect heart and lung health. The study will collect a variety of information from participants, including advanced imaging of the heart and lungs, details about their living conditions, psychological assessments, and medical histories. By examining this rich set of data, researchers hope to uncover important connections that could help prevent and manage cardiovascular diseases, which are conditions affecting the heart and blood vessels.

To participate in this study, you need to be at least 18 years old and have had a specific heart imaging test called coronary CT angiography. It's important to note that individuals with serious kidney or liver diseases, certain infections, or other specific health issues may not be eligible. If you join, you can expect to contribute to valuable research that could lead to better treatments and prevention strategies for heart and lung diseases. The study is currently looking for participants, and everyone's involvement could make a meaningful difference in understanding cardiovascular health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥18 years
• • Coronary CT angiography performed
• • Informed consent acquired
• Exclusion Criteria:
• • Unable to complete the follow-up
• • Serious chronic kidney disease (eGFR\< 30 ml/min/1.73 m2)
• • Serious liver disease or dysfunction (chronic active hepatitis and cirrhosis, or aspartate aminotransferase (AST) or alanine transaminase (ALT) \> 3 times the upper limit of normal)
• • Not appropriate to be tested due to birth planning, allergies, acute thyroid storm, etc.
• • Suspected or known infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), and Treponema pallidum (syphilis), etc.